Cart
sales@molnova.com
Procyanidin A2
CAS No. 41743-41-3
Procyanidin A2( —— )
Catalog No. M24379 CAS No. 41743-41-3
Procyanidin A2 is a potential precursor of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, exhibits antioxidant, anti-inflammary, anti-hyperglycemia, and anti-type 2 diabetes activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 297 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 351 | In Stock |
|
| 25MG | 584 | In Stock |
|
| 50MG | 808 | In Stock |
|
| 100MG | 1088 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProcyanidin A2
-
NoteResearch use only, not for human use.
-
Brief DescriptionProcyanidin A2 is a potential precursor of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, exhibits antioxidant, anti-inflammary, anti-hyperglycemia, and anti-type 2 diabetes activities.
-
DescriptionProcyanidin A2 is a potential precursor of 5-(3',4'-dihydroxyphenyl)-γ-valerolactone, exhibits antioxidant, anti-inflammary, anti-hyperglycemia, and anti-type 2 diabetes activities. Procyanidin A2 demonstrates liver cell regenerative activity in scratch wound healing assays and alcohol-induced liver cell injury in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorGLUT|IL Receptor|TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41743-41-3
-
Formula Weight576.51
-
Molecular FormulaC30H24O12
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (173.46 mM; Need ultrasonic)
-
SMILESO[C@H](C1)[C@@H](c(cc2)cc(O)c2O)Oc2c1c(O)cc1c2[C@H]([C@H]2O)c(c(O)cc(O)c3)c3O[C@@]2(c(cc2)cc(O)c2O)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Procyanidin A2 Modulates IL-4-Induced CCL26 Production in Human Alveolar Epithelial Cells.Int J Mol Sci. 2016 Nov 12;17(11). pii: E1888.
molnova catalog
related products
-
Pascolizumab
Pascolizumab (SB-240683) is a humanized monoclonal antibody targeting IL-4, exhibiting asthmatic effects and useful for studying allergic rhinitis.
-
Xeligekimab
Xeligekimab (GR 1501) is a fully human monoclonal antibody that selectively neutralizes IL-17A, has potential anti-inflammatory activity, and can be used to study plaque psoriasis.
-
Nothofagin
Nothofagin has antioxidant, and antithrombotic activities, it possesses anti-inflammatory activity by inhibiting hyperpermeability, expression of CAMs, and adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.
